UPL Fund Raise of ₹3,378 Cr

UPL Board Meeting Date

UPL schedules a 2 November 2026 board meeting to approve unaudited quarterly and half-year results, followed by an earnings call. The trading window stays closed until 48 hours after results are disseminated.

UPL Other Announcement

UPL Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.

UPL Credit Rating

CRISIL Ratings has revised UPL Limited's long-term bank facility outlook from 'Negative' to 'Stable', while reaffirming its 'CRISIL AA+' rating.

UPL Management Change

UPL Limited announced the departure of Mr. Toshan Tamhane, Group Chief Operating Officer, effective from the close of business hours on August 31, 2026.

UPL Merger & Restructuring Worth ₹1,045 Cr

UPL Ltd's subsidiary Advanta Holdings B.V. will acquire Misr Hytech Seed International S.A.E. for ~US$110 million (~₹1,045 Crore). This acquisition expands its seed market presence.

Value

₹1,045 Cr

Execution

On or before 31 January 2027

UPL Credit Rating

S&P Global Ratings has revised the credit rating outlook for UPL Corporation Limited from 'Stable' to 'Positive'. The 'BB' long-term issuer credit rating remains affirmed.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.